机构

• 上海药物研究所 [12]
• 上海营养与健康研究所 [3]
• 心理研究所 [2]
• 昆明植物研究所 [2]
• 武汉物理与数学研究所 [2]
• 南海海洋研究所 [1]
• 更多

采集方式

• OAI收割 [26]

内容类型

• 期刊论文 [26]

发表日期

• 2019 [26]

学科主题

• Cell Biolo... [1]
• Endocrinol... [1]
• Research &... [1]

筛选

浏览/检索结果: 共26条，第1-10条 帮助 限定条件 发表日期：2019     条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Homology modeling and 3D-QSAR study of benzhydrylpiperazine delta opioid receptor agonists 期刊论文  OAI收割 COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2019, 卷号: 83, 页码: 9 作者:  Pan, Chenling;  Meng, Hao;  Zhang, Shuqun;  Zuo, Zhili;  Shen, Yuehai   |  收藏  |  浏览/下载：19/0  |  提交时间：2020/03/18 delta opioid receptor agonists  3D-QSAR  Homology modeling  Molecular dynamics simulation  Molecular docking   Selective activation of TWIK-related acid-sensitive K+ 3 subunit-containing channels is analgesic in rodent models 期刊论文  OAI收割 SCIENCE TRANSLATIONAL MEDICINE, 2019, 卷号: 11, 期号: 519, 页码: 12 作者:  Liao, Ping;  Qiu, Yunguang;  Mo, Yiqing;  Fu, Jie;  Song, Zhenpeng   |  收藏  |  浏览/下载：40/0  |  提交时间：2020/07/01 Activation and function of receptor tyrosine kinases in human clear cell renal cell carcinomas 期刊论文  OAI收割 BMC CANCER, 2019, 卷号: 19, 期号: 1, 页码: 13 作者:  Zhang, Qing;  Liu, Jian-He;  Liu, Jing-Li;  Qi, Chun-Ting;  Yan, Lei   |  收藏  |  浏览/下载：65/0  |  提交时间：2020/07/01 Receptor tyrosine kinases (RTKs)  Activation and function  Clear cell renal cell carcinomas (ccRCCs)  Targeted therapy  PDGFR beta  Stroma cells   Current trends in drug metabolism and pharmacokinetics 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2019, 卷号: 9, 期号: 6, 页码: 1113-1144 作者:  Li, Yuhua;  Meng, Qiang;  Yang, Mengbi;  Liu, Dongyang;  Hou, Xiangyu   |  收藏  |  浏览/下载：34/0  |  提交时间：2020/07/01 Pharmacokinetics  Drug metabolism  Drug-drug interactions  Modeling  Metabolizing enzymes  Transporters  Nuclear receptors  Noncoding RNAs   Designing of novel ERR gamma inverse agonists by molecular modeling studies of docking and 3D-QSAR on hydroxytamoxifen derivatives 期刊论文  OAI收割 MEDICINAL CHEMISTRY RESEARCH, 2019, 卷号: 28, 期号: 10, 页码: 1661-1673 作者:  Li, Rui;  Du, Yongli;  Shen, Jingkang   |  收藏  |  浏览/下载：10/0  |  提交时间：2020/07/01 ERR gamma inverse agonist  Molecular docking  3D-QSAR  CoMFA  CoMSIA   Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models 期刊论文  OAI收割 JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 卷号: 38, 期号: 1, 页码: 16 作者:  Peng, Xia;  Hou, Pengcong;  Chen, Yi;  Dai, Yang;  Ji, Yinchun   |  收藏  |  浏览/下载：23/0  |  提交时间：2020/07/01 Kinase inhibitor  FGFR  CSF-1R  Tumor microenvironment   Vitamin D Regulates the Microbiota to Control the Numbers of ROR gamma t/FoxP3+Regulatory T Cells in the Colon 期刊论文  OAI收割 FRONTIERS IN IMMUNOLOGY, 2019, 卷号: 10, 页码: 10 作者:  Cantorna, Margherita T.;  Lin, Yang-Ding;  Arora, Juhi;  Bora, Stephanie;  Tian, Yuan   |  收藏  |  浏览/下载：45/0  |  提交时间：2019/10/14 vitamin D  T regulatory (T reg) cells  inflammatory bowel diseases  microbiota  gnotobiotic mice   SHR-A1403, a novel c-Met antibody-drug conjugate, exerts encouraging anti-tumor activity in c-Met-overexpressing models 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2019, 卷号: 40, 期号: 7, 页码: 971-979 作者:  Yang, Chang-yong;  Wang, Lei;  Sun, Xing;  Tang, Mi;  Quan, Hai-tian   |  收藏  |  浏览/下载：33/0  |  提交时间：2020/07/01 SHR-A1403  c-Met ADC  anti-tumor  patient-derived xenograft (PDX)  molecular mechanisms   Farnesoid X Receptor Constructs an Immunosuppressive Microenvironment and Sensitizes (FXRPD)-P-high-L1(low) NSCLC to Anti-PD-1 Immunotherapy 期刊论文  OAI收割 CANCER IMMUNOLOGY RESEARCH, 2019, 卷号: 7, 期号: 6, 页码: 990-1000 作者:  You, Wenjie;  Li, Lijun;  Sun, Deqiao;  Liu, Xueqing;  Xia, Zongjun   |  收藏  |  浏览/下载：21/0  |  提交时间：2020/07/01 Development and validation of a prognostic index for efficacy evaluation and prognosis of first-line chemotherapy in stage III-IV lung squamous cell carcinoma 期刊论文  OAI收割 EUROPEAN RADIOLOGY, 2019, 卷号: 29, 期号: 5, 页码: 2388-2398 作者:  Song, Jiangdian;  Tian, Jie;  Zhang, Lina;  Qu, Xiujuan;  Qian, Wei   |  收藏  |  浏览/下载：64/0  |  提交时间：2019/07/12 Biomarkers  Tumor  Carcinoma  Squamous cell  Prognosis